Part B Payment Model Indexing Commercial Discounts Proposed By Genentech - ResearchAndMarkets.com

DUBLIN--()--The "Part B Payment Model Indexing Commercial Discounts Proposed By Genentech" newsletter has been added to ResearchAndMarkets.com's offering.

Genentech, Inc. has designed a Medicare Market-based Pricing Model that replaces the average sales price (ASP) method currently used with a new approach, while retaining the current buy-and-bill system.

Learn more about this proposed model, which also provides a means for CMS to pass savings on to patients at the point of sale. Find out why Genentech believes the model would accelerate spur private-market negotiations and how it may affect overall ASP and Medicare reimbursement.

For more information about this newsletter visit https://www.researchandmarkets.com/r/hvivc8

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceutical Manufacturing

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceutical Manufacturing